As the aging population continues to grow – projected to be more than 20% of the U.S. by 2030 – remote patient monitoring is becoming an increasingly important healthcare option. A recent industry ...

Guidance on use of non-invasive remote monitoring devices for patient care during the coronavirus public health emergency was expanded and updated by the US Food and Drug Administration (FDA) on ...

On October 19, 2023, the U.S. Food and Drug Administration (FDA) issued Guidance for Industry and FDA Staff titled Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient ...

Remote patient monitoring is here to stay. Telemonitoring claims for Medicare beneficiaries increased sixfold between 2018 and 2021, in part due to relaxed COVID-19 pandemic rules. By one estimate, ...

The US Food and Drug Administration (FDA) has updated final guidance on its enforcement policy for remote patient monitoring devices in an effort to assist stakeholders in transitioning operations and ...

Many of the latest advances in remote monitoring for digital healthcare revolve around non-invasive devices and innovative technologies that reduce patient care costs while improving health outcomes.

Remote monitoring for patients with a variety of diseases has been on the increase since the emergence of the COVID pandemic. While hypertension is the leading diagnosis for monitoring, diabetes is ...

This review article presents a three-part true-life clinical vignette that illustrates how digital health technology can aid providers caring for patients with cardiovascular disease. Specific ...

Nearly 100 million remote patient monitoring devices are expected to ship over the next five years, according to ABI Research. An ABI Research news release indicates there are increasing opportunities ...

In what some industry observers saw as a setback for at-home patient monitoring, FDA's Circulatory System Devices Panel rejected the premarket approval application (PMA) for the Chronicle implantable ...